ESG risk score 38.92
Environmental score 4.52
Social score 25.14
Governance score 9.26
ESG risk category High
Negligible Low Med High Severe
0-10 10-20 20-30 30-40 40+
Orexo AB
000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol ORX:xome
Currency SEK
NASDAQ OMX Stockholm
Open Closed
15 minutes delayed
Data provided by 
This information is not currently available for this instrument. Refresh the page or try again later.
Want to start investing?
Trade stocks with a broker trusted by over 1.5 million clients. Investing involves risk. You may lose some or all of your investment.
Chart
This information is not currently available for this instrument. Refresh the page or try again later.
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
This information is not currently available for this instrument. Refresh the page or try again later.
Returns
Year to date (YTD) -33.82%
1 year 40.28%
3 years 59.36%
Data provided by 
Key stats
Price/earnings (LTM) -
Dividend yield (LTM) -
EPS (LTM) -3.74
Volatility (30 days) -
Data provided by
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Data provided by 
/ 
/ Financials
Q1 Q2 Q3 Q4
Income statement
Revenue XXXXXXX XXXXXXX XXXXXXX XXXXXXX
EBITDA XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Net income XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Balance sheet
Total assets XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Total debt XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Ratios
Price/sales XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Earnings per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Dividend per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Return on equity XXXXXXX XXXXXXX XXXXXXX XXXXXXX
About Orexo AB
Orexo AB is a Swedish pharmaceutical company dedicated to advancing treatments for severe diseases and life-saving rescue medications to meet future healthcare needs, developing improved medications based on proprietary drug delivery technologies. At the core of its innovation is AmorphOX, which improves bioavailability and stability for both large and small molecules. It has developed four drugs from concept to approval, including Zubsolv, Abstral, Edluar, and Diabact UBT. The company's current development efforts focus on AmorphOX, with projects in preclinical and clinical phases across multiple therapeutic areas. It operates through US Commercial and HQ & Pipeline, which generate maximum revenue, and operates in the US, EU, and UK generating maximum revenue, and the Rest of the World.
Sector Healthcare
Industry -
Market cap 0.699718964bn
Data provided by /
/ Others were interested in
This information is not currently available for this instrument. Refresh the page or try again later.
Frequently asked questions
To buy Orexo AB stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Orexo AB by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Orexo AB is ORX:xome. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Orexo AB has its primary listing on NASDAQ OMX Stockholm. You can trade Orexo AB with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Orexo AB is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Orexo AB as part of a broader investment portfolio.